Fig. 3

The procedure for tumour-specific NIRF imaging. a Conjugation and purification processes of IRDye800CW and antibodies against OC183B2 and mouse immunoglobulin G1 (IgG1) (isotype control). b Design of tumour-specific NIRF imaging of COC183B2-800 in a subcutaneous mouse tumour model. c Imaging of purified antibodies conjugated with IRDye800CW